Literature DB >> 16963308

Gene therapy and transplantation in CNS repair: the visual system.

Alan R Harvey1, Ying Hu, Simone G Leaver, Carla B Mellough, Kevin Park, Joost Verhaagen, Giles W Plant, Qi Cui.   

Abstract

Normal visual function in humans is compromised by a range of inherited and acquired degenerative conditions, many of which affect photoreceptors and/or retinal pigment epithelium. As a consequence the majority of experimental gene- and cell-based therapies are aimed at rescuing or replacing these cells. We provide a brief overview of these studies, but the major focus of this review is on the inner retina, in particular how gene therapy and transplantation can improve the viability and regenerative capacity of retinal ganglion cells (RGCs). Such studies are relevant to the development of new treatments for ocular conditions that cause RGC loss or dysfunction, for example glaucoma, diabetes, ischaemia, and various inflammatory and neurodegenerative diseases. However, RGCs and associated central visual pathways also serve as an excellent experimental model of the adult central nervous system (CNS) in which it is possible to study the molecular and cellular mechanisms associated with neuroprotection and axonal regeneration after neurotrauma. In this review we present the current state of knowledge pertaining to RGC responses to injury, neurotrophic and gene therapy strategies aimed at promoting RGC survival, and how best to promote the regeneration of RGC axons after optic nerve or optic tract injury. We also describe transplantation methods being used in attempts to replace lost RGCs or encourage the regrowth of RGC axons back into visual centres in the brain via peripheral nerve bridges. Cooperative approaches including novel combinations of transplantation, gene therapy and pharmacotherapy are discussed. Finally, we consider a number of caveats and future directions, such as problems associated with compensatory sprouting and the reformation of visuotopic maps, the need to develop efficient, regulatable viral vectors, and the need to develop different but sequential strategies that target the cell body and/or the growth cone at appropriate times during the repair process.

Entities:  

Mesh:

Year:  2006        PMID: 16963308     DOI: 10.1016/j.preteyeres.2006.07.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  25 in total

1.  Influence of callosal transfer on visual cortical evoked response and the implication in the development of a visual prosthesis.

Authors:  Timothy L Siu; John W Morley
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-19       Impact factor: 3.117

2.  Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury.

Authors:  Arthur J Weber; Suresh Viswanáthan; Chidambaram Ramanathan; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-26       Impact factor: 4.799

3.  A comprehensive negative regulatory program controlled by Brn3b to ensure ganglion cell specification from multipotential retinal precursors.

Authors:  Feng Qiu; Haisong Jiang; Mengqing Xiang
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

4.  Intravitreal injection of AAV2 transduces macaque inner retina.

Authors:  Lu Yin; Kenneth Greenberg; Jennifer J Hunter; Deniz Dalkara; Kathleen D Kolstad; Benjamin D Masella; Robert Wolfe; Meike Visel; Daniel Stone; Richard T Libby; David Diloreto; David Schaffer; John Flannery; David R Williams; William H Merigan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

5.  Injectable Neurotrophic Factor Delivery System Supporting Retinal Ganglion Cell Survival and Regeneration Following Optic Nerve Crush.

Authors:  Melissa R Laughter; James R Bardill; David A Ammar; Brisa Pena; David J Calkins; Daewon Park
Journal:  ACS Biomater Sci Eng       Date:  2018-07-23

6.  Partial Transection of Adult Rat Optic Nerve as a Model of Secondary Degeneration in the Central Nervous System.

Authors:  Carole A Bartlett; Melinda Fitzgerald
Journal:  Bio Protoc       Date:  2018-12-20

7.  Virally delivered, constitutively active NFκB improves survival of injured retinal ganglion cells.

Authors:  Galina Dvoriantchikova; Steve Pappas; Xueting Luo; Marcio Ribeiro; Dagmara Danek; Daniel Pelaez; Kevin K Park; Dmitry Ivanov
Journal:  Eur J Neurosci       Date:  2016-09-13       Impact factor: 3.386

8.  BDNF treatment and extended recovery from optic nerve trauma in the cat.

Authors:  Arthur J Weber; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-09       Impact factor: 4.799

9.  Retinal ganglion cell survival and axon regeneration in WldS transgenic rats after optic nerve crush and lens injury.

Authors:  Barbara Lorber; Alessia Tassoni; Natalie D Bull; Marilita M Moschos; Keith R Martin
Journal:  BMC Neurosci       Date:  2012-06-06       Impact factor: 3.288

Review 10.  Planet of the AAVs: The Spinal Cord Injury Episode.

Authors:  Katerina Stepankova; Pavla Jendelova; Lucia Machova Urdzikova
Journal:  Biomedicines       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.